Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2004-09-20
2010-10-12
Nashed, Nashaat T (Department: 1656)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S325000, C435S252300, C435S252330, C435S254200, C435S069100, C435S069400, C435S070100, C435S071100, C514S04400A
Reexamination Certificate
active
07812146
ABSTRACT:
The present invention relates to a hybrid Hepatocyte Growth Factor (HGF) gene which is prepared by inserting an inherent or foreign intron between exons 4 and 5 in HGF cDNA, which has a base sequence of SEQ ID NO: 2. The gene has high expression efficiency and simultaneously expresses two heterotypes of HGF and dHGF (deleted variant HGF). Further the gene may be used for treating or preventing ischemic or liver diseases.
REFERENCES:
patent: 5328836 (1994-07-01), Shima et al.
patent: 5500354 (1996-03-01), Kitamura et al.
patent: 5587359 (1996-12-01), Higashio et al.
patent: 6121246 (2000-09-01), Isner
patent: 6248722 (2001-06-01), Morishita et al.
patent: 6258787 (2001-07-01), Isner
patent: 6316419 (2001-11-01), Leiden et al.
patent: 7285540 (2007-10-01), Morishita et al.
patent: 2003/0148968 (2003-08-01), Hammond et al.
patent: 2003/0171287 (2003-08-01), Morishita et al.
patent: 2004/0105882 (2004-06-01), Morishita et al.
patent: 2004/0228834 (2004-11-01), Isner et al.
patent: 2006/0286072 (2006-12-01), Giordano et al.
patent: 2009/0004260 (2009-01-01), Morishita et al.
patent: 2009/0082293 (2009-03-01), Giordano et al.
patent: 2009/0131350 (2009-05-01), Kim et al.
patent: 2009/0202606 (2009-08-01), Kim et al.
patent: WO 98/50079 (1998-11-01), None
patent: WO 99/45775 (1999-09-01), None
patent: WO 01/34208 (2001-05-01), None
patent: WO 02/089856 (2002-11-01), None
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Potrykus, Gene transfer to cereals: an assessment, Biotechnology, 1990, 8(6):535-542.
Witkowski et al., Biochemistry, 38, 11643-11650, 1999.
Wishart et al., Journal of Biological Chemistry, vol. 270, No. 45, pp. 26782-26785, 1995.
Kisselev, Structure, vol. 10, pp. 8-9, 2002.
Courtney et al. (GenBank Accession No. AC004960 available since Jun. 12, 1998, Retrieved from Internet: http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=3845412).
Liu, Y., “The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization,”Gene 215:159-169, Elsevier Science B.V. (1998).
Seki, T., et al., “Organization of the human hepatocyte growth factor-encoding Gene,”Gene 102:213-219, Elsevier Science Publishers B.V. (1991).
Supplementary European Search Report for European Application No. EP 03 74 4561, European Patent Office, Netherlands, mailed Apr. 18, 2006.
Miyazawa, K., et al., “Molecular Cloning and Sequence Analysis of cDNA for Human Hepatocyte Growth Factor,”Biochem. Biophys. Res. Commun. 163:967-973, Academic Press (1989).
Nakamura, T., et al., “Molecular cloning and expression of human hepatocyte growth factor,”Nature 342:440-443, Macmillan Journals Ltd. (1989).
Seki, T., et al., “Isolation and expression of cDNA for Different Forms of Hepatocyte Growth Factor from Human Leukocyte,”Biochem. Biophys. Res. Commun. 172:321-327, Academic Press (1990).
Shima, N., et al., “Hepatocyte Growth Factor and its Variant with a Deletion of Five Amino Acids are Distinguishable in their Biological Activity and Tertiary Structure,”Biochem. Biophys. Res. Commun. 200:808-815, Academic Press (1994).
NCBI Entrez, GenBank Database, Accession No. AC004960, “Homo sapiensPAC clone RP5-1098B1 from 7q11.23-q21, complete sequence,” 51 pages (first available 1998).
Deng, et al., “Secretory Expression of the Deleted Variant of Human Hepatocyte Growth Factor (hdHGF) inPichia pastoris,” Chinese Journal of Biochemistry and Molecular Biology17:590-594 (2001), China Academic Journal Electronic Publishing House, Beijing, China.
Rubin, et al., “A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor,”Proc. Natl. Acad. Sci. USA88:415-419 (Jan. 1991), Proceedings of the National Academy of Sciences of the United States of America, 500 5th St., Washington, DC 20001.
Warnecke, et al., “Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements,”Biochem. J. 340:17-24 (May 15, 1999), Portland Press Limited, Third Floor, Eagle House, 16 Procter Street, London, WC1V6NX.
Hahn Woong
Kim Jong-Mook
Park Eun-Jin
Lee Jae W
Nashed Nashaat T
Sterne Kessler Goldstein & Fox P.L.L.C.
ViroMed Co., Ltd.
LandOfFree
Hybrid hepatocyte growth factor gene having high expression... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid hepatocyte growth factor gene having high expression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid hepatocyte growth factor gene having high expression... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4213646